By Martin Arendts
The pharmaceutical and medical supplies provider B. Braun Melsungen AG gets out of the hospital operator RHÖN-KLINIKUM AG. B. Braun has accepted the takeover offer by the Hamburg hospital group Asklepios, which wants to take over RHÖN completely. The background is a joint venture agreed between RHÖN-KLINIKUM company founder Eugen Münch and Asklepios: https://spruchverfahren.blogspot.com/2020/02/asklepios-und-rhon-klinikum-grunder.html
B. Braun is ending its multi-year engagement with RHÖN, the company said. The pharmaceutical and medical supplies provider has been a major shareholder in RHÖN-KLINIKUM AG since 2013 and most recently held around 25 % of the shares. B. Braun had long bitterly resisted the takeover of RHÖN. At an extraordinary general meeting in early June, B. Braun unsuccessfully attempted to have several members of the RHÖN supervisory board, including company founder and chief controller Eugen Münch, dismissed.
Asklepios wants to take over RHÖN-KLINIKUM AG completely and shorten the gap to industry leader Fresenius Helios - with the help of RHÖN founder and partner Münch. Together, they already held more than 50% of RHÖN shares. The remaining shareholders were offered a takeover bid for EUR 18 per share, which the Management Board and the Supervisory Board had approved.
The Federal Cartel Office (Bundeskartellamt) approved the proposed takeover. Negotiations are ongoing at RHÖN about the separation of boss Stephan Holzinger. With B. Braun's exit from Rhön and the transfer of the shares, Asklepios is taking a big step closer to the goal of fully taking over the clinic operator.
Regarding the takeover offer on the BaFin website:
https://www.bafin.de/SharedDocs/Downloads/DE/Angebotsunterlage/rhoen_klinikum_ag.html;jsessionid=2A957B42A6AAA4FA48B56910E97C60E7.2_cid392?nn=7845970
The pharmaceutical and medical supplies provider B. Braun Melsungen AG gets out of the hospital operator RHÖN-KLINIKUM AG. B. Braun has accepted the takeover offer by the Hamburg hospital group Asklepios, which wants to take over RHÖN completely. The background is a joint venture agreed between RHÖN-KLINIKUM company founder Eugen Münch and Asklepios: https://spruchverfahren.blogspot.com/2020/02/asklepios-und-rhon-klinikum-grunder.html
B. Braun is ending its multi-year engagement with RHÖN, the company said. The pharmaceutical and medical supplies provider has been a major shareholder in RHÖN-KLINIKUM AG since 2013 and most recently held around 25 % of the shares. B. Braun had long bitterly resisted the takeover of RHÖN. At an extraordinary general meeting in early June, B. Braun unsuccessfully attempted to have several members of the RHÖN supervisory board, including company founder and chief controller Eugen Münch, dismissed.
Asklepios wants to take over RHÖN-KLINIKUM AG completely and shorten the gap to industry leader Fresenius Helios - with the help of RHÖN founder and partner Münch. Together, they already held more than 50% of RHÖN shares. The remaining shareholders were offered a takeover bid for EUR 18 per share, which the Management Board and the Supervisory Board had approved.
The Federal Cartel Office (Bundeskartellamt) approved the proposed takeover. Negotiations are ongoing at RHÖN about the separation of boss Stephan Holzinger. With B. Braun's exit from Rhön and the transfer of the shares, Asklepios is taking a big step closer to the goal of fully taking over the clinic operator.
Regarding the takeover offer on the BaFin website:
https://www.bafin.de/SharedDocs/Downloads/DE/Angebotsunterlage/rhoen_klinikum_ag.html;jsessionid=2A957B42A6AAA4FA48B56910E97C60E7.2_cid392?nn=7845970
No comments:
Post a Comment